Certuity’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Sell
2,430
-143
-6% -$26.9K 0.02% 404
2026
Q1
$464K Buy
2,573
+479
+23% +$92.4K 0.03% 312
2025
Q4
$385K Buy
2,094
+127
+6% +$22.3K 0.02% 336
2025
Q3
$302K Sell
1,967
-187
-9% -$28.3K 0.02% 393
2025
Q2
$301K Sell
2,154
-34
-2% -$4.76K 0.03% 295
2025
Q1
$322K Buy
2,188
+82
+4% +$11.9K 0.03% 248
2024
Q4
$276K Sell
2,106
-34
-2% -$4.76K 0.03% 275
2024
Q3
$333K Buy
2,140
+414
+24% +$66.8K 0.04% 240
2024
Q2
$269K Buy
+1,726
New +$260K 0.02% 282

Other funds holding AZN

Certuity's AZN Position: Q2 2026 in Review

Certuity reduced its AstraZeneca (AZN) stake by 5.6% in Q2 2026, selling an estimated $26.9K and leaving 2,430 shares worth $420K. The position accounts for 0.02% of the portfolio, ranked #404.

Certuity first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $464K in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Certuity held 2,430 shares of AstraZeneca worth $420K as of Q2 2026.
  • Certuity sold 143 AstraZeneca shares in Q2 2026, an estimated $26.9K.
  • AstraZeneca made up 0.02% of Certuity's portfolio in Q2 2026, its #404 holding.
  • Certuity first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
  • Certuity's AstraZeneca position peaked at $464K in Q1 2026.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.